150 related articles for article (PubMed ID: 23025948)
21. Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma.
Peng ZW; Liu FR; Ye S; Xu L; Zhang YJ; Liang HH; Lin XJ; Lau WY; Chen MS
Cancer; 2013 Nov; 119(21):3812-20. PubMed ID: 23922119
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria--a comparative study.
Lai EC; Tang CN
Int J Surg; 2013; 11(1):77-80. PubMed ID: 23220487
[TBL] [Abstract][Full Text] [Related]
23. Solitary colorectal liver metastasis: resection determines outcome.
Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
[TBL] [Abstract][Full Text] [Related]
24. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.
Maluccio M; Covey AM; Gandhi R; Gonen M; Getrajdman GI; Brody LA; Fong Y; Jarnagin W; D'Angelica M; Blumgart L; DeMatteo R; Brown KT
J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503
[TBL] [Abstract][Full Text] [Related]
25. Results of liver resection in combination with radiofrequency ablation for hepatic malignancies.
Eisele RM; Zhukowa J; Chopra S; Schmidt SC; Neumann U; Pratschke J; Schumacher G
Eur J Surg Oncol; 2010 Mar; 36(3):269-74. PubMed ID: 19726155
[TBL] [Abstract][Full Text] [Related]
26. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
[TBL] [Abstract][Full Text] [Related]
27. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey.
Hasegawa K; Kokudo N; Makuuchi M; Izumi N; Ichida T; Kudo M; Ku Y; Sakamoto M; Nakashima O; Matsui O; Matsuyama Y
J Hepatol; 2013 Apr; 58(4):724-9. PubMed ID: 23178708
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
[TBL] [Abstract][Full Text] [Related]
29. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas.
Kim GA; Shim JH; Kim MJ; Kim SY; Won HJ; Shin YM; Kim PN; Kim KH; Lee SG; Lee HC
Br J Surg; 2016 Jan; 103(1):126-35. PubMed ID: 26572697
[TBL] [Abstract][Full Text] [Related]
31. Experience with more than 500 minimally invasive hepatic procedures.
Buell JF; Thomas MT; Rudich S; Marvin M; Nagubandi R; Ravindra KV; Brock G; McMasters KM
Ann Surg; 2008 Sep; 248(3):475-86. PubMed ID: 18791368
[TBL] [Abstract][Full Text] [Related]
32. Hepatic resection assisted by ablative therapy for advanced hepatocellular carcinoma.
Hiraoka A; Tazuya N; Hidaka S; Uehara T; Ichiryu M; Nakahara M; Tanabe A; Shimizu Y; Tanihira T; Hasebe A; Miyamoto Y; Ninomiya T; Kawasaki H; Ochi H; Koizumi Y; Hirooka M; Abe M; Hiasa Y; Matsuura B; Onji M; Michitaka K
Hepatogastroenterology; 2011; 58(107-108):955-9. PubMed ID: 21830423
[TBL] [Abstract][Full Text] [Related]
33. Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?
Huang J; Yan L; Wu H; Yang J; Liao M; Zeng Y
J Surg Res; 2016 Jan; 200(1):122-30. PubMed ID: 26277218
[TBL] [Abstract][Full Text] [Related]
34. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population.
Schwarz RE; Smith DD
Am J Surg; 2008 Jun; 195(6):829-36. PubMed ID: 18436176
[TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.
Peng ZW; Zhang YJ; Chen MS; Lin XJ; Liang HH; Shi M
Eur J Surg Oncol; 2010 Nov; 36(11):1054-60. PubMed ID: 20846819
[TBL] [Abstract][Full Text] [Related]
36. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
[TBL] [Abstract][Full Text] [Related]
37. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey.
Hasegawa K; Makuuchi M; Takayama T; Kokudo N; Arii S; Okazaki M; Okita K; Omata M; Kudo M; Kojiro M; Nakanuma Y; Takayasu K; Monden M; Matsuyama Y; Ikai I
J Hepatol; 2008 Oct; 49(4):589-94. PubMed ID: 18620773
[TBL] [Abstract][Full Text] [Related]
38. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
39. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
[TBL] [Abstract][Full Text] [Related]
40. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
